NS Investment Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 5
Professionals
  • Investments
  • 22
  • Portfolio
  • 9
  • Exits
  • 12
Exits

NS Investment General Information

Description

Founded in 2015, NS Investment is the corporate venture capital arm of Dong-A ST Company and is based in Seoul, South Korea. The firm seeks to invest in the healthcare and life sciences sector.

Contact Information

Website
www.nsinvest.co.kr
Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Primary Office
  • 203 Sin-A Building 50
  • Seosomun-ro 11-gil, Jung-gu
  • Seoul, 04519
  • South Korea
+82 00-000-0000

NS Investment Investments (22)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Dewpoint 03-Feb-2022 Later Stage VC 00000 Drug Discovery Generating Revenue
0000 000000000000 10-Jan-2022 00000 00000 00000 Biotechnology Generating Revenue
000000000 00000000 02-Nov-2021 00000 00000 00000 Drug Discovery Pre-Clinical Trials
000000 00000000000 13-Oct-2021 00000 00000 0000 Drug Delivery Generating Revenue
000000000 00000000 18-Aug-2021 00000 00000 0000 Biotechnology Generating Revenue
000000 00000000000 04-Aug-2021 00000 00000 00000 Drug Discovery Pre-Clinical Trials
000000000 00000000 12-Nov-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2
000000 00000000000 23-Apr-2020 00000 00000 0000 Biotechnology Generating Revenue
Silverback Therapeutics 11-Mar-2020 Early Stage VC 000.00 Biotechnology Clinical Trials - Phase 1
Xilio Therapeutics 02-Mar-2020 Early Stage VC 00000 Drug Discovery Clinical Trials - Phase 1
You’re viewing 10 of 22 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NS Investment Exits (12)

Company Name Exit Date Exit Type Exit Size
Xilio Therapeutics 22-Oct-2021 IPO 00000
00000000 11-Aug-2021 0000000 000000 0000
000000 & 00 23-Dec-2020 000 000.00
0000000000 0000000 04-Dec-2020 000 00000
0000 0000000000000 24-Apr-2020 000 00000
0000000 0000000000 18-Jul-2019 000 0000
0000000 0000000000 27-Jun-2019 000 0000
00000000 09-May-2019 000 0000
Harpoon Therapeutics 08-Feb-2019 IPO 0000
ABL Bio 22-Dec-2018 IPO 000.00
You’re viewing 10 of 12 exits. Get the full list »

NS Investment Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

NS Investment Team (6)

Name Title Deals Funds Boards Office
Kiel Kim Chief Executive Officer 0 0 0 Seoul, South Korea
TK Sohn Chief Executive Officer Seoul, South Korea
Kevin Sha Director Seoul, South Korea
Ian Heo Associate Director Seoul, South Korea
Pavel Printsev Associate Director Seoul, South Korea
You’re viewing 5 of 6 team members. Get the full list »

NS Investment Co-Investors (128)

Name With Exits Lead Partner Series Industry
OrbiMed 6 0 0 Series chart Industry bar
EcoR1 Capital 0 0 Series chart Industry bar
Alexandria Venture Investments 0 Series chart Industry bar
Casdin Capital 0 0 Series chart Industry bar
The Column Group 0 0 0 Series chart Industry bar
You’re viewing 5 of 128 co-investors. Get the full list »